Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 79

Speech Recognition With LLMs Adapted to Disordered Speech Using Reinforcement Learning w/ Dr. Subhashini Venugopalan of University of Texas.

Speakers: Cecile Tamura, Subhashini Venugopalan

Read more | >

Scientists and engineers from the University of Bristol and the UK Atomic Energy Authority (UKAEA) and have successfully created the world’s first carbon-14 diamond battery.

This new type of battery has the potential to power devices for thousands of years, making it an incredibly long-lasting energy source.

The battery leverages the radioactive isotope, carbon-14, known for its use in radiocarbon dating, to produce a diamond battery.

Read more | >

International research team unveils the first electrically pumped continuous-wave semiconductor laser designed for seamless integration with silicon.

Scientists from Forschungszentrum Jülich (FZJ), the University of Stuttgart, the Leibniz Institute for High Performance Microelectronics (IHP), and their French partner CEA-Leti have successfully developed the first electrically pumped continuous-wave semiconductor laser made entirely from group IV elements, commonly referred to as the “silicon group” in the periodic table.

This innovative laser is constructed from stacked ultrathin layers of silicon-germanium-tin and germanium-tin. Remarkably, it is the first laser of its type to be directly grown on a silicon wafer, paving the way for advancements in on-chip integrated photonics. The research findings have been published in the prestigious journal Nature Communications.

Read more | >

Stimulating dopamine-producing brain cells wirelessly with gold nanoparticles has proven effective at treating mice with Parkinson’s disease, even reversing a portion of their neurological damage.

Researchers from the National Center for Nanoscience and Technology of China (NCNST) say it’s a significant step forward for using brain simulation to tackle Parkinson’s in humans, a neurodegenerative condition that affects more than 10 million people worldwide.

Deep inside the brains of those with the condition, dopamine-producing neurons take a major hit as insoluable clumps of a protein called alpha-synuclein accumulate, gradually depriving patients of an ability to control their movements.

Read more | >

SpaceX is preparing to launch the seventh Starship flight test. The window for the launch opens at 4 p.m. local time on Monday. The company has confirmed on its website, and X, that it is targeting a potential catch of the Super Heavy booster, if flight parameters allow for it. SpaceX will also try to re-ignite a single Raptor engine in space to demonstrate deorbit capabilities. This flight is the first one, that will feature the new upgraded Starship upper stage!

Window Opens: January 15th at 4PM CST (22:00 UTC)
Window Closes: January 15th at 5PM CST (23:00 UTC)

Mission: Starship’s seventh fully integrated test flight.
Launch location: Orbital Launch Pad A, Starbase, Earth.
Target orbit: Trans-atmospheric.
Booster: Booster 14
Booster recovery: Orbital Launch Pad A launch tower arms.
Ship: Ship 33
Ship recovery: Will attempt soft splashdown on the Indian Ocean.
Rocket trajectory: Straight east over the Gulf of Mexico.
Payload: 10 Starlink simulators.
Stats:
· SpaceX’s 7th launch of the year and the 7th launch of the month.
· Starship’s 7th launch.
· 3rd Super Heavy recovery attempt, hopefully the 2nd successful one.

⚡ Become a member of NASASpaceflight’s channel for exclusive discord access, fast turnaround clips, and other exclusive benefits. Your support helps us continue our 24/7 coverage. ⚡

Continue reading “🚀 SpaceX Launches Starship Flight 7 and Attempts Another Booster Catch” | >

Starbase #Starship #SpaceX

Join us for LIVE coverage from Starbase, Texas of SpaceX’s 7th Flight Test of Starship including the SECOND CATCH ATTEMPT.

Pad : OLP-1 location : starbase, texas, USA rocket : starship. booster : TBD ship : TBD

– — – — – — – — – — – — – — – -

Continue reading “LIVE! SpaceX Starship Flight 7 Countdown” | >

Snakebites affect 1.8 to 2.7 million people annually, causing around 100,000 deaths and three times as many permanent disabilities, according to the World Health Organization. Victims are predominantly in regions with fragile healthcare systems, such as Africa, Asia, and Latin America. Traditional antivenoms derived from animal plasma come with significant drawbacks: high costs, limited efficacy, and serious side effects.

The diversity of snake venoms further complicates treatment, as current antivenoms often target specific species. However, advances in toxin research and computational tools are now driving a new era in snakebite therapy.

Baker’s team, in collaboration with Timothy Patrick Jenkins from Denmark’s Technical University (DTU), harnessed AI to design proteins that bind to and neutralize three-finger toxins—among the deadliest components of cobra venom. These toxins are notorious for evading the immune system, rendering conventional treatments ineffective.

Read more | >